Dr. Scott Robert Schultz, MD

Dr. Schultz practices at Dialysis Access of Minnesota, L.L.C. in Minneapolis, Minnesota.

Dr. Schultz's NPI, 1821098872, was assigned on July 29, 2005. Dr. Schultz graduated from Georgetown University School of Medicine in 1989. Dr. Schultz holds Minnesota license 38328.

Dr. Schultz's primary practice is Dialysis Access of Minnesota, L.L.C., at 2800 Campus Dr, Minneapolis, MN 55441 in Hennepin County. The practice phone is (763) 432-4300.

Dr. Schultz's primary practice is Dialysis Access of Minnesota, L.L.C. in Minneapolis, Minnesota. Dr. Schultz is also affiliated with North Memorial Health - Robbinsdale Hospital. The medical group on file is North Memorial Health. Dmand AI also links Dr. Schultz to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultz practices, 2 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Schultz's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Schultz is licensed in Minnesota.

CMS data shows 373 Medicare services from Dr. Schultz across 15 procedure codes in 2024, for 397 Medicare patients. Medicare paid $27,557 for them.

CMS counts 397 Medicare patients who saw Dr. Schultz in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 4.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schultz's median patient age at 67, with 52% women.

In 2021, Dr. Schultz wrote 12 Medicare Part D claims. They cover 1 drug, with $59 in total drug cost. In 2020, CMS named 15 claims across 1 drug.

Dr. Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Schultz to 1 clinical trial. Conditions studied include Arteriovenous Fistula and Vascular Fistula. Open Payments lists research payments to Dr. Schultz that name 1 trial.

CMS Open Payments shows 453 general payments to Dr. Schultz from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Abbott Laboratories paid the most, $43,020. It also lists 17 research payments totaling $41,640 from 2016 to 2024, naming 1 clinical trial.

Dr. Schultz graduated from Georgetown University School of Medicine in 1989.